Carregant...

A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening

INTRODUCTION: Clinical decision-making in the setting of CT screening could benefit from accessible biomarkers that help predict the level of lung cancer risk in high-risk individuals with indeterminate pulmonary nodules. METHODS: To identify candidate serum biomarkers, we measured 70 cancer-related...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bigbee, William L., Gopalakrishnan, Vanathi, Weissfeld, Joel L., Wilson, David O., Dacic, Sanja, Lokshin, Anna E., Siegfried, Jill M.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3308353/
https://ncbi.nlm.nih.gov/pubmed/22425918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31824ab6b0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!